Multiple Sclerosis Trial, Recruiting NCT05010902 Sponsor: Charite University, Berlin, Germany Condition: Multiple Sclerosis
Back to Multiple Sclerosis

Multiple Sclerosis Trial, Recruiting

NCT05010902
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You must be older than 18 years of age
  • You must be willing to sign a consent form agreeing to take part in the trial
  • You must have been diagnosed with multiple sclerosis or a first episode of symptoms that may suggest multiple sclerosis (sometimes called "clinically isolated syndrome")

Who may not be able to join:

  • You may not be able to join if you have other significant health conditions alongside your MS diagnosis (confirm with trial site)
  • You may not be able to join if you are unable to have an MRI scan, for example if you have a pacemaker, certain metal implants in your body, or are allergic to the dye used during some MRI scans (called gadolinium)
  • You may not be able to join if you currently have problems with alcohol or drug misuse

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 13 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
1 January 2013
Est. completion
31 December 2025

Where this trial is recruiting

🇩🇪 Germany

Primary endpoints

Time until relapse

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 13 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov